awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34949678-AF5EEEF4-B73D-460C-8D33-A9DAA2614F93
Q34949678-AF5EEEF4-B73D-460C-8D33-A9DAA2614F93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-AF5EEEF4-B73D-460C-8D33-A9DAA2614F93
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
P1476
Q34949678-AF5EEEF4-B73D-460C-8D33-A9DAA2614F93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-AF5EEEF4-B73D-460C-8D33-A9DAA2614F93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25d135e79bc9f173c76a37547eba5601b3fb611f
P1476
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
@en